Epimedium and Improved Efficacy Rate

• The efficacy and safety of Epimedium in the treatment of primary osteoporosis: a systematic review and meta-analysis.

  • 2025-09-19
  • Systematic Review · n = 10
  • Frontiers in medicine 12
  • • Xian-Quan Zhang
    • Zhen-Hui Hua
    • Chu-Jia Huang
    • Hai-Yun Chen
    • Zong-Ren Hu
    • Mei-Ren Zhang
    • Jun Liu

  • PubMed: 41048931
  • DOI: 10.3389/fmed.2025.1675160

  9 Insights on

  • Improved Efficacy Rate

  • High evidence
  • Clinical

  Meta-analysis suggests that the overall efficacy rate of the Epimedium group was significantly higher than that of the control group (OR = 3.80; 95% CI: 2.27,6.37; p = 0.0001).

  Effect

  Beneficial

  Effect size

  Large

  Significant

  Yes